Related Experiment Video
Updated: Mar 19, 2026
07:58
Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression
Published on: February 24, 2023
957
[Challenges for and potential approaches to deprescribing].
Carina Lundby1,2, Jesper Ryg3,4,5, Anton Pottegård1,2
1Sygehusapotek Fyn, Odense Universitetshospital.
Ugeskrift for Laeger
|March 18, 2026
Summary
Understanding patient, relative, and healthcare professional attitudes is key to successful deprescribing. Addressing barriers like lack of guidance and resource constraints improves shared decision-making and patient care.
Area of Science:
- Gerontology
- Pharmacology
- Health Services Research
Background:
- Deprescribing medications is crucial for optimizing patient outcomes and reducing polypharmacy.
- Differing attitudes among stakeholders present significant challenges to effective deprescribing.
Purpose of the Study:
- To review and summarize the attitudes of patients, relatives, and healthcare professionals regarding deprescribing.
- To identify barriers and facilitators influencing deprescribing decisions.
Main Methods:
- Systematic review of literature on stakeholder attitudes towards deprescribing.
- Analysis of patient, relative, and healthcare professional perspectives.
Main Results:
- Patients may have conflicting views on stopping medications.
- Relatives significantly influence deprescribing decisions.
- Healthcare professionals face barriers including lack of clear guidance, uncertainty about risks/benefits, and resource limitations.
Conclusions:
- Awareness of diverse stakeholder perspectives is essential for successful deprescribing.
- Structured tools, clear guidelines, and patient involvement can enhance shared decision-making.
- Improving deprescribing practices can lead to better clinical outcomes and patient well-being.
More Related Videos
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
687
04:29Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
29.8K
Related Concept Videos
01:28Drug Therapy
376
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
376
01:25Antidepressant Drugs: Overview
1.9K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.9K
01:23Antidepressant Drugs: MAOIs and Other Agents
1.1K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.1K
01:26Psychosis: Goals of Pharmacotherapy
653
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
653
01:28Depressants
560
Depressant drugs, including alcohol and sedative-hypnotics, diminish central nervous system activity by enhancing the action of gamma-aminobutyric acid (GABA), a neurotransmitter that reduces brain activity and promotes relaxation. These substances can have various therapeutic uses but also pose significant risks, especially when misused or combined.
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
560
01:20Desensitization and Tachyphylaxis
3.3K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
3.3K